Lipopolysaccharide-induced loss of cultured rat myenteric neurons - Role of AMP-activated protein kinase

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Voss, Ulrikke ^a   Ekblad, Eva ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ESCHERICHIA COLI LIPOPOLYSACCHARIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; VASOACTIVE INTESTINAL POLYPEPTIDE; (6-(4-(2-PIPERIDIN-1-YLETHOXY)PHENYL))-3-PYRIDIN-4-YLPYRAZOLO(1,5-A)PYRIMIDINE; LIPOPOLYSACCHARIDE; MAP KINASE KINASE KINASE 7; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; PYRAZOLE DERIVATIVE; PYRIMIDINE DERIVATIVE;

ANIMAL CELL; ARTICLE; CELL LOSS; CELL SURVIVAL; CONTROLLED STUDY; ENTERIC NEURONAL LOSS; ENZYME ACTIVATION; ENZYME REGULATION; FEMALE; IMMUNOCOMPETENT CELL; IMMUNOCYTOCHEMISTRY; INNATE IMMUNITY; INTESTINE INNERVATION; NERVE CELL CULTURE; NEUROIMMUNOLOGY; NEUROPROTECTION; NONHUMAN; PERIKARYON; RAT; UPREGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; METABOLISM; MYENTERIC PLEXUS; NERVE CELL; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

RATTUS;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; CELL SURVIVAL; CELLS, CULTURED; FEMALE; LIPOPOLYSACCHARIDES; MAP KINASE KINASE KINASES; MYENTERIC PLEXUS; NEURONS; PYRAZOLES; PYRIMIDINES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84914665563     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0114044     Document Type: Article

References (54)

1. Backhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI (2005) Host-bacterial mutualism in the human intestine. Science 307: 1915-1920.
2. Clemente JC, Ursell LK, Parfrey LW, Knight R (2012) The Impact of the Gut Microbiota on Human Health: An Integrative View. Cell 148: 1258-1270.
3. Kim KA, Gu W, Lee IA, Joh EH, Kim DH (2012) High Fat Diet-Induced Gut Microbiota Exacerbates Inflammation and Obesity in Mice via the TLR4 Signaling Pathway. Plos One 7.
4. Camilleri M, Madsen K, Spiller R, Van Meerveld BG, Verne GN (2012) Intestinal barrier function in health and gastrointestinal disease. Neurogastroenterology and Motility 24: 503-512.
5. Wouters MM, Boeckxstaens GE (2011) Neuroimmune mechanisms in functional bowel disorders. Netherlands Journal of Medicine 69: 55-61.
6. West AP, Koblansky AA, Ghosh S (2006) Recognition and signaling by toll-like receptors. Annual Review of Cell and Developmental Biology. Palo Alto: Annual Reviews. pp. 409-437.
7. Landström M (2010) The TAK1-TRAF6 signalling pathway. Int J Biochem Cell Biol 42: 585-589.
8. Arciszewski M, Pierzynowski S, Ekblad E (2005) Lipopolysaccharide induces cell death in cultured porcine myenteric neurons. Digestive Diseases and Sciences 50: 1661-1668.
9. Arciszewski MB, Sand E, Ekbad E (2008) Vasoactive intestinal peptide rescues cultured rat myenteric neurons from lipopolysaccharide induced cell death. Regulatory Peptides 146: 218-223.
10. Gomariz RP, Arranz A, Juarranz Y, Gutierrez-Canas I, Garcia-Gomez M, et al. (2007) Regulation of TLR expression, a new perspective for the role of VIP in immunity. Peptides 28: 1825-1832.
11. Viollet B, Horman S, Leclerc J, Lantier L, Foretz M, et al. (2010) AMPK inhibition in health and disease. Critical Reviews in Biochemistry and Molecular Biology 45: 276-295.
12. Leff T (2003) AMP-activated protein kinase regulates gene expression by direct phosphorylation of nuclear proteins. Biochemical Society Transactions 31: 224-227.
13. Labuzek K, Liber S, Gabryel B, Okopien B (2010) AICAR (5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside) increases the production of toxic molecules and affects the profile of cytokines release in LPS-stimulated rat primary microglial cultures. Neurotoxicology 31: 134-146.
14. Labuzek K, Liber S, Gabryel B, Buldak L, Okopien B (2010) Ambivalent effects of compound C (dorsomorphin) on inflammatory response in LPS-stimulated rat primary microglial cultures. Naunyn-Schmiedebergs Archives of Pharmacology 381: 41-57.
15. Kim SY, Jeong S, Jung E, Baik KH, Chang MH, et al. (2012) AMP-activated protein kinase-alpha 1 as an activating kinase of TGF-beta-activated kinase 1 has a key role in inflammatory signals. Cell Death & Disease 3: 1-13.
16. Bai AP, Ma AG, Yong M, Weiss CR, Ma YB, et al. (2010) AMPK agonist downregulates innate and adaptive immune responses in TNBS-induced murine acute and relapsing colitis. Biochemical Pharmacology 80: 1708-1717.
17. Salminen A, Hyttinen JMT, Kaarniranta K (2011) AMP-activated protein kinase inhibits NF-kappa B signaling and inflammation: impact on healthspan and lifespan. Journal of Molecular Medicine-Jmm 89: 667-676.
18. Voss U, Sand E, Hellstrom PM, Ekblad E (2012) Glucagon-like peptides 1 and 2 and vasoactive intestinal peptide are neuroprotective on cultured and mast cell co-cultured rat myenteric neurons. Bmc Gastroenterology 12: 30.
19. Sand E, Voss U, Hammar O, Alm R, Nordin Fredrikson G, et al. (2012) Gonadotropin-releasing hormone analog buserelin causes neuronal loss in rat gastrointestinal tract. Cell Tissue Res.
20. Ekblad E, Ekman R, Hakanson R, Sundler F (1988) Projections of peptide-containing neurons in rat colon. Neuroscience 27: 655-674.
21. Voss U, Sand E, Olde B, Ekblad E (2013) Enteric neuropathy can be induced by high fat diet in vivo and palmitic acid exposure in vitro. PLoS One 8: e81413.
22. Wu J, Powell F, Larsen NA, Lai Z, Byth KF, et al. (2013) Mechanism and in vitro pharmacology of TAK1 inhibition by (5Z)-7-Oxozeaenol. ACS Chem Biol 8: 643-650.
23. Corton JM, Gillespie JG, Hawley SA, Hardie DG (1995) 5-aminoimidazole-4-carboxamide ribonucleoside - a specific method for activating AMP-activated protein-kinase in intact-cells. European Journal of Biochemistry 229: 558-565.
24. Goransson O, McBride A, Hawley SA, Ross FA, Shpiro N, et al. (2007) Mechanism of action of A-769662, a valuable tool for activation of AMP-activated protein kinase. Journal of Biological Chemistry 282: 32549-32560.
25. Zhang Y, Wang Y, Bao C, Xu Y, Shen H, et al. (2012) Metformin interacts with AMPK through binding to γ subunit. Mol Cell Biochem 368: 69-76.
26. Hardie DG, Ross FA, Hawley SA (2012) AMP-activated protein kinase: a target for drugs both ancient and modern. Chem Biol 19: 1222-1236.
27. Ghanim H, Abuaysheh S, Sia CL, Korzeniewski K, Chaudhuri A, et al. (2009) Increase in Plasma Endotoxin Concentrations and the Expression of Toll-like Receptors and Suppressor of Cytokine Signaling-3 in Mononuclear Cells After a High-Fat, High-Carbohydrate Meal Implications for insulin resistance. Diabetes Care 32: 2281-2287.
28. Adhikari A, Xu M, Chen ZJ (2007) Ubiquitin-mediated activation of TAK1 and IKK. Oncogene 26: 3214-3226.
29. Xie M, Zhang D, Dyck JR, Li Y, Zhang H, et al. (2006) A pivotal role for endogenous TGF-beta-activated kinase-1 in the LKB1/AMP-activated protein kinase energy-sensor pathway. Proc Natl Acad Sci U S A 103: 17378-17383.
30. Momcilovic M, Hong SP, Carlson M (2006) Mammalian TAK1 activates Snf1 protein kinase in yeast and phosphorylates AMP-activated protein kinase in vitro. Journal of Biological Chemistry 281: 25336-25343.
31. Chen ZY, Shen XL, Shen FY, Zhong W, Wu H, et al. (2013) TAK1 activates AMPK-dependent cell death pathway in hydrogen peroxide-treated cardiomyocytes, inhibited by heat shock protein-70. Molecular and Cellular Biochemistry 377: 35-44.
32. Anitha M, Vijay-Kumar M, Sitaraman SV, Gewirtz AT, Srinivasan S (2012) Gut Microbial Products Regulate Murine Gastrointestinal Motility via Toll-Like Receptor 4 Signaling. Gastroenterology 143: 1006-+.
33. Everard A, Belzer C, Geurts L, Ouwerkerk JP, Druart C, et al. (2013) Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proceedings of the National Academy of Sciences of the United States of America 110: 9066-9071.
34. Wexler HM (2007) Bacteroides: the good, the bad, and the nitty-gritty. Clinical Microbiology Reviews 20: 593-+.
35. Maeshima N, Fernandez RC (2013) Recognition of lipid A variants by the TLR4-MD-2 receptor complex. Frontiers in Cellular and Infection Microbiology 3: 13.
36. Miller SI, Ernst RK, Bader MW (2005) LPS, TLR4 and infectious disease diversity. Nat Rev Microbiol 3: 36-46.
37. Voss U, Sand E, Olde B, Ekblad E (2013) Enteric neuropathy can be induced by high fat diet in vivo and palmitic acid exposure in vitro. PLOS ONE SUBMITTED.
38. McCullough LD, Zeng ZY, Li H, Landree LE, McFadden J, et al. (2005) Pharmacological inhibition of AMP-activated protein kinase provides neuroprotection in stroke. Journal of Biological Chemistry 280: 20493-20502.
39. Poels J, Spasic MR, Callaerts P, Norga KK (2009) Expanding roles for AMP-activated protein kinase in neuronal survival and autophagy. Bioessays 31: 944-952.
40. Jiang PZ, Gan M, Ebrahim AS, Castanedes-Casey M, Dickson DW, et al. (2013) Adenosine monophosphate-activated protein kinase overactivation leads to accumulation of alpha-synuclein oligomers and decrease of neurites. Neurobiology of Aging 34: 1504-1515.
41. Neubert M, Ridder DA, Bargiotas P, Akira S, Schwaninger M (2011) Acute inhibition of TAK1 protects against neuronal death in cerebral ischemia. Cell Death and Differentiation 18: 1521-1530.
42. Zhang D, Hu Y, Sun Q, Zhao J, Cong Z, et al. (2013) Inhibition of transforming growth factor beta-activated kinase 1 confers neuroprotection after traumatic brain injury in rats. Neuroscience 238: 209-217.
43. Scott JW, van Denderen BJW, Jorgensen SB, Honeyman JE, Steinberg GR, et al. (2008) Thienopyridone Drugs Are Selective Activators of AMP-Activated Protein Kinase beta 1-Containing Complexes. Chemistry & Biology 15: 1220-1230.
44. Hawley SA, Gadalla AE, Olsen GS, Hardie DG (2002) The antidiabetic drug metformin activates the AMP-activated protein kinase cascade via an adenine nucleotide-independent mechanism. Diabetes 51: 2420-2425.
45. Sakamoto K, Goransson O, Hardie DG, Alessi DR (2004) Activity of LKB1 and AMPK-related kinases in skeletal muscle: Effects of contraction, phenformin, and AICAR. American Journal of Physiology-Endocrinology and Metabolism 287: E310-E317.
46. Fryer LGD, Parbu-Patel A, Carling D (2002) The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways. Journal of Biological Chemistry 277: 25226-25232.
47. Zhou G, Myers R, Li Y, Chen Y, Shen X, et al. (2001) Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 108: 1167-1174.
48. Wilcock C, Bailey CJ (1994) Accumulation of metformin by tissues of the normal and diabetic mouse. Xenobiotica 24: 49-57.
49. Ekblad E, Mulder H, Sundler F (1996) Vasoactive intestinal peptide expression in enteric neurons is upregulated by both colchicine and axotomy. Regulatory Peptides 63: 113-121.
50. Sandgren K, Lin Z, Svenningsen AF, Ekblad E (2003) Vasoactive intestinal peptide and nitric oxide promote survival of adult rat myenteric neurons in culture. Journal of Neuroscience Research 72: 595-602.
51. Gadalla AE, Pearson T, Currie AJ, Dale N, Hawley SA, et al. (2004) AICA riboside both activates AMP-activated protein kinase and competes with adenosine for the nucleoside transporter in the CA1 region of the rat hippocampus. Journal of Neurochemistry 88: 1272-1282.
52. Lanner JT, Georgiou DK, Dagnino-Acosta A, Ainbinder A, Cheng Q, et al. (2012) AICAR prevents heat-induced sudden death in RyR1 mutant mice independent of AMPK activation. Nature Medicine 18: 244-251.
53. Canto C, Auwerx J (2010) AMP-activated protein kinase and its downstream transcriptional pathways. Cellular and Molecular Life Sciences 67: 3407-3423.
54. Goodman RH (1990) REGULATION OF NEUROPEPTIDE GENE-EXPRESSION. Annual Review of Neuroscience 13: 111-127.